Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Wilms Tumor × Data Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 15 Papillomavirus Infections 9 Uterine Cervical Neoplasms 6 Pancreatic Neoplasms 5 Breast Neoplasms 5 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Neuroendocrine Tumors 4 Neoplasm Metastasis 4 Multiple Myeloma 3 Lymphoma 3 Autoimmune Diseases 3 Thyroid Diseases 2 Pancreatic Cyst 2 Neuroblastoma 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 COVID-19 2 Abortion, Spontaneous 2 Wilms Tumor 1

Interventions

Cyclophosphamide 14 Vincristine 12 Filgrastim 10 Etoposide 10 Radiotherapy 9 Doxorubicin 9 X-Rays 8 Phantoms, Imaging 8 Granulocyte Colony-Stimulating Factor 8 Carboplatin 8 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Temozolomide 6 Melphalan 6 Peripheral Blood Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 Irinotecan 5 Ifosfamide 5 Dactinomycin 5 Busulfan 5 Biopsy 5 sargramostim 4 Topotecan 4 Stem Cell Transplantation 4 Polymerase Chain Reaction 4 fludarabine 3 Reverse Transcriptase Polymerase Chain Reaction 3 Radiation 3 Nivolumab 3 Mesna 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04423484 2026-03-02

GFANEPHRO20

French Africa Pediatric Oncology Group

Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡